GSK Consumer soars 20 pct on parent's open offer plan
MUMBAI (Reuters) - Shares in GlaxoSmithKline Consumer Healthcare (GLSM.NS), the Indian arm of GlaxoSmithKline (GSK.L), surged 20 percent to their maximum daily limit on Monday, following news that its UK-based parent group plans to raise its stake in the unit via an open offer.
GlaxoSmithKline Plc (GSK.L), along with its units, will buy up to 13.39 million shares, or an additional 31.84 percent in GlaxoSmithKline Consumer Healthcare, at 3,900 rupees per share, said HSBC Securities, the manager to the offer, in a statement.
Valued at $2.3 billion, shares in GSK Consumer Healthcare were locked at 3,659.20 rupees, up 20 percent to their maximum daily trading limit, while the Sensex was up 0.42 percent by 9:36 a.m. (Reporting by Kaustubh Kulkarni and Manoj Dharra; Editing by Jijo Jacob)
- Tweet this
- Share this
- Digg this
- Disarray in Congress after poll drubbing
- China-Brazil satellite launch fails, likely fell back to Earth
- Reliance Industries, Bharti sign telecom infrastructure deal
- UPDATE 3-U.S. regulators seek to curb Wall St trades with Volcker rule
- Obama and Castro shake hands, Zuma humiliated at Mandela memorial
Disarray within the Congress burst into the open on Tuesday after its stunning defeat in state elections, with a senior figure saying the party would lose a general election and needed time in opposition to reinvent itself. Article